EPTIS
BAM Logo

Search a Proficiency Testing (PT) scheme in the database

Country
Page 1 of 1 (Hits 1 to 9 of 9)
ID
Country
PT provider
PT scheme
Last changed
947164 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - Coronavirus (SARS-CoV2): antigen research by automation [EP Clínico - Coronavírus (SARS-CoV2): pesquisa de antígeno por automação] Clinical PT - Coronavirus (SARS-CoV2): antigen research by automation [EP Clínico - Coronavírus (SARS-CoV2): pesquisa de antígeno por automação] 2022-07-26
PT name (Clinical PT - Coronavirus (SARS-CoV2): antigen research by automation)
Scheme name in national language (EP Clínico - Coronavírus (SARS-CoV2): pesquisa de antígeno por automação)
Test item (Lyophilized cell suspension (inactivated virus))
Tested property (Coronavirus (SARS-CoV2): antigen research by automation)

1009007 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva [EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva] Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva [EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva] 2023-01-31
PT name (Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva)
Scheme name in national language (EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva)
Test item (lyophilized cell suspension or lyophilized human saliva (virus inactivated))
Tested property (Molecular Biology - Coronavirus (SARS-CoV2): saliva)

880833 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - Molecular panel of Respiratory Infections and Pneumonia [EP Clínico - Painel Molecular para Infecções Respiratórias e Pneumonias] Clinical PT - Molecular panel of Respiratory Infections and Pneumonia [EP Clínico - Painel Molecular para Infecções Respiratórias e Pneumonias] 2023-05-29
Tested property (Coronavírus (SARS-CoV-2)) (Respiratory Syncytial Virus) (Respiratory Syncytial Virus A) (Respiratory Syncytial Virus B)

690909 Argentina ILT - Interlaboratory Test S.A. ILT - Interlaboratory Test S.A. ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease) ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease) 2020-06-09
PT name (ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease))

690914 Argentina ILT - Interlaboratory Test S.A. ILT - Interlaboratory Test S.A. Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112 Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112 2020-09-16
PT name (Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112)

134427 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing Water Microbiology Scheme - (QWAS) Water Microbiology Scheme - (QWAS) 2021-03-01
Tested property (SARS-CoV-2) (Detection of SARS-CoV-2) (Optional quantification of SARS-CoV-2 (Trial))
Testing method (2 x 1.5 ml vial (A & B) of non-infectious, SARS-CoV-2 virus (whole genome) 1 x >100ml sterile water diluent 1 x >20g sterile sludge matrix) (0 to 10000 virus copies per ml)

769005 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing SARS-CoV-2 Proficiency Testing Scheme SARS-CoV-2 Proficiency Testing Scheme 2022-05-04
PT name (SARS-CoV-2 Proficiency Testing Scheme)
Test item (SARS-CoV-2 (Serological)- 3 x 0.75 ml samples for detection for the SARS-CoV-2 antibodies -NEW 2020) (SARS-CoV-2 (Molecular)- 2 x 1.5ml samples for SARS-CoV-2 virus -NEW 2020) (SARS-CoV-2 antigen - 3 x swab based samples (A, B, and C). Non-infectious simulated patient) (nasopharyngeal samples containing the SARS-CoV-2 nucleocapsid protein.) (SARS-CoV-2 (Molecular)- 2 x swab based samples. Non-infectious simulated nasopharyngeal samples)
Tested property (SARS-CoV-2 IgA, IgG, IgM, Total antibodies) (SARS-CoV-2 virus) (SARS-CoV-2 virus) (SARS-CoV-2 virus - The samples contain the whole genome) (SARS-CoV-2 virus - The samples contain the whole genome)

706310 Portugal Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ SARS-CoV-2, molecular detection [SARS-CoV-2, molecular detection] SARS-CoV-2, molecular detection [SARS-CoV-2, molecular detection] 2024-03-13
PT name (SARS-CoV-2, molecular detection)
Scheme name in national language (SARS-CoV-2, molecular detection)
Tested property (SARS-CoV-2 virus)

794057 Australia RCPAQAP RCPAQAP PHLN: SARS-CoV-2 and other coronaviruses PHLN: SARS-CoV-2 and other coronaviruses 2020-10-23
PT name (PHLN: SARS-CoV-2 and other coronaviruses)
Remarks (laboratory testing platforms that are utilised in the whole genome sequencing of SARS-CoV-2. Available) (free of charge to Australian public health laboratories that require the capability to test for SARS-CoV-2.)
Test item (Inactivated virus for Whole genome sequencing)
Tested property (Diluted SARS-CoV-2 (inactivated)) (Diluted SARS-CoV-2 (inactivated))

Page 1 of 1 (Hits 1 to 9 of 9)
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5